LIU Min, WANG Ying. Levetiracetam versus oxcarbazepine in the treatment of partial seizures in adults with epilepsy[J]. Journal of Clinical Medicine in Practice, 2020, 24(15): 35-37,41. DOI: 10.7619/jcmp.202015010
Citation: LIU Min, WANG Ying. Levetiracetam versus oxcarbazepine in the treatment of partial seizures in adults with epilepsy[J]. Journal of Clinical Medicine in Practice, 2020, 24(15): 35-37,41. DOI: 10.7619/jcmp.202015010

Levetiracetam versus oxcarbazepine in the treatment of partial seizures in adults with epilepsy

More Information
  • Received Date: May 05, 2020
  • Published Date: September 09, 2020
  • Objective To compare the efficacy of levetiracetam and oxcarbazepine in the treatment of partial seizures in adults with epilepsy. Methods A total of 142 adult patients with partial seizures in adults with epilepsy were randomly divided into two groups according to computer randomized method, with 71 cases in each group. The control group was treated with levetiracetam and the observation group was treated with oxcarbazepine. The curative effect, electroencephalogram changes and adverse reaction rate before and after treatment were compared between the two groups. Results The total effective rate was 81.69% in the observation group, and 69.01% in the control group, but there was no significant difference(P>0.05). After treatment, the relative power of θ frequency band in the observation group was(30.76±6.84)%, which was significantly higher than(22.03±6.72)% in the control group(P<0.05). The ratio of patients with interictal epileptiform discharges(IEA)reducing more than 50% was 60.56% in the observation group, and was 54.93% in the control group, and there was no significant difference(P>0.05). The incidence of adverse reactions was 9.86% in the observation group, and 12.68% in the control group, but there was no significant difference(P>0.05). Conclusion Levetiracetam and oxcarbazepine are effective and safe in the treatment of partial seizures in adults, and can significantly inhibit IEA, but oxacepine has greater influence on activity of electroencephalogram.
  • 苏绮璇, 侯小兵. 左乙拉西坦对癫痫患者血清细胞因子及认知状态相关指标的影响[J]. 海南医学, 2017, 28(22):3648-3651.
    谭向红, 宋志彬, 王珲, 等. 左乙拉西坦辅助治疗对难治性癫痫部分性发作患者血清神经细胞因子、凋亡分子的影响[J]. 海南医学院学报, 2017, 23(11):1575-1578.
    许向军, 周志明. 癫痫的诊断和治疗[J]. 中华全科医学, 2019, 17(10):1619-1620.
    高勇. 创伤性难治性癫痫患者应用卡马西平、托吡酯和左乙拉西坦联合治疗的临床效果研究[J]. 中国医师进修杂志, 2018, 41(3):212-215.
    田丽, 胡佳. 探讨丙戊酸钠联合奥卡西平治疗癫痫的临床疗效和对炎性因子的影响[J]. 四川解剖学杂志, 2019, 27(3):13-15.
    蒋东波, 李满连. 左乙拉西坦治疗癫痫的临床疗效及其安全性[J]. 临床合理用药杂志, 2019, 12(12):19-20.
    刘晓加, 吕田明. 临床神经内科急诊学[M]. 北京:科学技术文献出版社, 2009:496-496.
    劳动和社会保障部, 中华医学会, 中国抗癫痫协会. 中国癫痫临床诊疗指南[M]. 北京:人民卫生出版社, 2013:1-4.
    张双, 金超, 张静, 等. 左乙拉西坦、奥卡西平对部分性发作癫痫患儿的临床疗效及脑电图的影响[J]. 中国妇幼保健, 2015, 30(32):5679-5681.
    佘晓佳, 吴国栋, 孟祥红, 等. 左乙拉西坦联合中药治疗部分性癫痫发作疗效及对脑电图的影响[J]. 现代中西医结合杂志, 2018, 27(9):993-996.
    姜文燕, 李红健, 王婷婷, 等. 儿童三种新型抗癫痫药物血药浓度监测结果分析[J]. 中国药师, 2017, 20(10):1795-1798.
    李欣潞, 许虹. 奥卡西平治疗颞叶癫痫患者认知功能障碍的研究进展[J]. 中国药房, 2019, 30(13):1868-1872.
    王清香, 贾淑梅. 奥卡西平结合心理疗法治疗青少年癫痫120例疗效观察[J]. 安徽医药, 2019, 23(4):812-815.
    周宇航. 左乙拉西坦联合奥卡西平对癫痫患儿脑电图及智力的改善作用分析[J]. 包头医学, 2019, 43(1):8-10.
    温天盛, 陈美燕, 刘娟琼, 等. 奥卡西平联合左乙拉西坦治疗癫痫的效果及对甲状腺激素水平的影响分析[J]. 吉林医学, 2019, 40(6):1290-1292.
    陈金莹, 陈莎莎, 郑娴, 等. 左乙拉西坦联合拉莫三嗪对癫痫部分性发作患者脑电图和认知功能的影响[J]. 浙江中西医结合杂志, 2019, 29(8):663-665.
    田苗, 张丽, 徐玉, 等. 奥卡西平和丙戊酸钠对成人部分性癫痫患者脑电图及相关血液学指标水平的影响[J]. 国际检验医学杂志, 2017, 38(11):1477-1479.
    张兰. 奥卡西平治疗脑卒中后癫痫效果及对脑电图、血清NSE、TNF-α水平的影响[J]. 国际医药卫生导报, 2018, 24(14):2107-2109.
  • Cited by

    Periodical cited type(14)

    1. 李小叶,李德忠,刘叶君. 白细胞介素及胎儿纤维连接蛋白水平对早产的预测价值. 中国医师杂志. 2022(01): 101-104 .
    2. 郝灿灿. 硝苯地平联合盐酸利托君治疗先兆早产的临床研究. 大医生. 2022(20): 29-31 .
    3. 马依努·阿尔沙. 盐酸利托君配伍紧急宫颈环扎治疗晚期难免流产的效果. 中国继续医学教育. 2021(25): 149-153 .
    4. 张红敏,宋继荣. 先兆早产患者应用盐酸利托君和硫酸镁的临床价值对比. 海峡药学. 2020(01): 146-147 .
    5. 费腾. 分析不同宫缩抑制剂治疗先兆早产患者的疗效及对产妇和围生儿结局的影响. 中国医药指南. 2020(19): 52-53 .
    6. 罗丽萍,童焰. 硫酸镁联合盐酸利托君在胎膜早破患者中的疗效观察及对妊娠结局的影响研究. 当代医学. 2019(30): 157-158 .
    7. 冯敏. 利托君治疗胎膜早破型先兆早产的临床效果观察. 中外医学研究. 2019(30): 129-130 .
    8. 张青霞,吴思懿,吴莹莹. 盐酸利托君治疗先兆早产的临床效果观察. 临床合理用药杂志. 2019(35): 82-83 .
    9. 莫小跃,吴敏. 盐酸利托君与硫酸镁治疗先兆早产的效果及不良反应探讨. 中国医药科学. 2018(05): 79-81+98 .
    10. 沈雪艳,张国华,张微. 乳杆菌对先兆早产患者生殖道免疫微环境的影响及意义. 山东医药. 2018(28): 83-85 .
    11. 李翠丽. 盐酸利托君对于早产胎膜早破患者的临床治疗效果探究. 天津药学. 2018(03): 39-41 .
    12. 亓露,齐慧丽. 盐酸利托君在妊娠期糖尿病孕妇先兆早产中的应用. 北方药学. 2018(12): 48-49 .
    13. 魏然. 保胎灵胶囊辅助治疗先兆早产的可行性分析. 实用中西医结合临床. 2018(12): 135-137 .
    14. 王慧娟. 硝苯地平与盐酸利托君在早产产妇中的应用效果及安全性比较. 临床医学. 2017(12): 113-114 .

    Other cited types(1)

Catalog

    Article views (550) PDF downloads (14) Cited by(15)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return